scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1048758485 |
P356 | DOI | 10.1186/S12885-016-2185-5 |
P932 | PMC publication ID | 4763451 |
P698 | PubMed publication ID | 26907172 |
P5875 | ResearchGate publication ID | 295672427 |
P50 | author | Andreas Behren | Q39062050 |
Anderly C. Chueh | Q42426472 | ||
Jonathan Cebon | Q64683306 | ||
Mercedes Dávalos-Salas | Q85412101 | ||
P2093 | author name string | Matthew Anaka | |
Pu-Han Lo | |||
Aparna Jayachandran | |||
Prashanth Prithviraj | |||
Ramyar Molania | |||
Marzena Walkiewicz | |||
P2860 | cites work | Expression and localization of five members of the testis-specific serine kinase (Tssk) family in mouse and human sperm and testis | Q24296903 |
Sperm protein 17 is expressed in the sperm fibrous sheath | Q24314692 | ||
Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted | Q24652381 | ||
Brick by brick: metabolism and tumor cell growth | Q24656187 | ||
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond | Q27026323 | ||
Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines | Q28140799 | ||
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
Mitochondrial respiration--an important therapeutic target in melanoma | Q28482377 | ||
Mouse TEX15 is essential for DNA double-strand break repair and chromosomal synapsis during male meiosis | Q28512197 | ||
Loss of R2D2 proteins ROPN1 and ROPN1L causes defects in murine sperm motility, phosphorylation, and fibrous sheath integrity | Q28587968 | ||
Cancer/testis antigens, gametogenesis and cancer | Q29616129 | ||
On respiratory impairment in cancer cells | Q29617276 | ||
Otto Warburg's contributions to current concepts of cancer metabolism | Q29617601 | ||
Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer | Q33420388 | ||
TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization | Q33668662 | ||
Metabolic genes in cancer: their roles in tumor progression and clinical implications | Q33772469 | ||
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis | Q33946905 | ||
Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy | Q33997798 | ||
Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation | Q34043101 | ||
Therapy for metastatic melanoma: the past, present, and future. | Q34183225 | ||
Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma | Q34221697 | ||
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. | Q34363872 | ||
Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. | Q34424875 | ||
Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer | Q34430373 | ||
The molecular determinants of de novo nucleotide biosynthesis in cancer cells | Q34939794 | ||
Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect | Q35605096 | ||
Minimization of thermodynamic costs in cancer cell invasion | Q36583159 | ||
Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. | Q36793719 | ||
Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells | Q37071513 | ||
Role of PET in the initial staging of cutaneous malignant melanoma: systematic review | Q37326157 | ||
Tumor suppressors and cell metabolism: a recipe for cancer growth | Q37390879 | ||
Metabolic approaches to treatment of melanoma. | Q37622612 | ||
Lactate: a metabolic key player in cancer | Q37956296 | ||
Update on the current state of melanoma incidence | Q38026612 | ||
How does cancer cell metabolism affect tumor migration and invasion? | Q38153177 | ||
Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies | Q38208748 | ||
Systemic treatment for BRAF-mutant melanoma: where do we go next? | Q38235584 | ||
No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients | Q38245356 | ||
Anaplastic nephroblastomas express transketolase-like enzyme 1. | Q38423205 | ||
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? | Q38973075 | ||
TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer | Q39035923 | ||
The Ludwig institute for cancer research Melbourne melanoma cell line panel | Q39175905 | ||
Importance of glycolysis and oxidative phosphorylation in advanced melanoma | Q39264242 | ||
EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies | Q39524428 | ||
Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer | Q39686388 | ||
Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo | Q39732592 | ||
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. | Q39883131 | ||
Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines | Q39937372 | ||
Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. | Q39957913 | ||
Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells | Q40167027 | ||
Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle | Q40800971 | ||
The role of glucose metabolism and glucose-associated signalling in cancer. | Q42174809 | ||
TKTL-1 expression in lung cancer | Q43658651 | ||
Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells | Q45397670 | ||
Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors. | Q46759205 | ||
Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome | Q48661799 | ||
Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. | Q50940011 | ||
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. | Q53100877 | ||
Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy. | Q53242145 | ||
Is transketolase-like protein, TKTL1, transketolase? | Q54320672 | ||
Metabolic dysregulation in melanoma: cause or consequence? | Q54361978 | ||
Melanoma | Q56428909 | ||
2-Deoxy-D-[1-3H]glucose uptake by MCF7 and T47D breast tumour cells under conditions of active proliferation and serum deprivation | Q74797260 | ||
Effects of thiamine deficiency and of oxythiamine on rat tissue transketolase | Q76455047 | ||
Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer | Q79889033 | ||
Tumor antigen expression in melanoma varies according to antigen and stage | Q82506715 | ||
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate | Q82655417 | ||
Limited SP17 expression within tumors diminishes its therapeutic potential | Q85395151 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 134 | |
P577 | publication date | 2016-02-22 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells | |
P478 | volume | 16 |
Q36265702 | A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions. |
Q92596041 | APC/CCDH1 synchronizes ribose-5-phosphate levels and DNA synthesis to cell cycle progression |
Q42650181 | Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia |
Q39251886 | EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer |
Q41388484 | Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients |
Q59350205 | Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma |
Q40163628 | Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. |
Q46166592 | Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer |
Q61447992 | The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.